Navigation Links
UMass Medical School researchers receive $8.5M grant award to fight AIDS
Date:10/24/2007

WORCESTER, Mass. As the HIV/AIDS epidemic continues around the globe laying claim to more than 25 million lives and infecting over 39 million, researchers continue to search for both a cure and improved treatments for those suffering with this disease. Now the leading cause of death worldwide among 15 to 59 year olds, AIDS is a remarkably resilient adversary with the potent ability to evolve rapidly. This evolution dramatically complicates treatment, decreasing the effectiveness of existing drugs and necessitating the continual development of new therapeutics. University of Massachusetts Medical School Professor of Biochemistry & Molecular Pharmacology Celia A. Schiffer, PhD, is at the forefront of investigations to elucidate how HIV develops resistance to current drugs.

As a principal investigator of a National Institutes of Health Institute of General Medical Sciences Program Project Grant first awarded in 2001, Dr. Schiffer has comprised a stellar team of scientists from around the nation to develop HIV drugs that are less vulnerable to drug resistance. In recognition of the success of her efforts, Schiffer was recently awarded a full, five-year renewal of the project, Targeting Ensembles of Drug Resistant HIV-Protease. The renewal, totaling more than $8.5 million, will speed studies that seek a better understanding of inhibitor recognition and the development of new methodologies for designing inhibitors against HIV and other viruses and infections that have a propensity for acquiring drug resistance.

According to Terry R. Flotte, MD, executive deputy chancellor of UMMS and dean of the School of Medicine, the renewal reflects the NIHs confidence in Schiffers scientific aims. This work clearly illustrates how the advance of molecular biology can lead to direct benefit to patients. Dr. Schiffer's efforts to define exactly how HIV can become resistant to current drugs are vital to the development of better strategies to control HIV/AIDS.
'/>"/>

Contact: Kelly Bishop
kelly.bishop@umassmed.edu
508-856-2000
University of Massachusetts Medical School
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. UCLA Study Shows One-Third of Drug Ads in Medical Journals Do Not Contain References Supporting Medical Claims
2. Automatic extraction of gene/protein biological functions from biomedical text
3. Vital step in cellular migration described by UCSD medical researchers
4. Breakthrough method in nanoparticle synthesis paves the way for new pharmaceutical and biomedical applications
5. Medical molecules designed to respond to visible light that can penetrate tissue
6. Medical whistleblowers speak out
7. UCSD medical/bioengineering reseachers show titanium debris satobtage artificial joints
8. Innovative coating could give medical implants a longer life
9. Natural tumor suppressor in body discovered by UCSD medical researchers
10. Protein synthesis can be controlled by light, opening way for new scientific, medical applications
11. Modified collagen could yield important medical applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2014)... A fast-sensitive "electronic-nose" for sniffing the highly infectious bacteria ... stomach cramps, has been developed by a team at ... the research team has demonstrated that it is possible ... which would lead to rapid diagnosis of the ... could be possible to identify different strains of the ...
(Date:8/31/2014)... past several decades, malaria diagnosis has changed very little. After ... the blood across a glass slide, stains it with a ... parasite, which causes the disease. This approach gives an accurate ... an important measure of disease severity but is not ... research team from the Singapore-MIT Alliance for Research and Technology ...
(Date:8/29/2014)... from the University of Texas Medical Branch at Galveston has ... antibodies can completely protect monkeys against a lethal dose of ... time when the disease is severe. , Thomas Geisbert, professor ... Nature discussing advances in Ebola treatment research. The filoviruses ... most deadly of pathogens, with fatality rates of up to ...
Breaking Biology News(10 mins):Scientists develop 'electronic nose' for rapid detection of C. diff infection 2A new way to diagnose malaria 2A new way to diagnose malaria 3Leading Ebola researcher at UTMB says there's an effective treatment for Ebola 2
... , April 30, 2013 /PRNewswire-iReach/ -- Clinilabs, an early phase ... industry, today announced the arrival of Dr. Admir ... provide expertise in the development of drugs to treat pain, ... clinical trials. Dr. Admir Hadzic ...
... integrates three large sets of genomic data available through ... that might predict survival in patients with the most ... researchers at the Ohio State University Comprehensive Cancer Center ... Solove Research Institute (OSUCCC James) initially analyzed messenger ...
... whales sing complex songs in tropical waters during the ... latitudes at other times of the year. NOAA ... whale movements to acoustic behavior on a feeding ground ... published April 10 in the journal PLOS ONE ...
Cached Biology News:Clinilabs Welcomes Anesthesiologist Dr. Admir Hadzic Who Will Provide CSF/cCSF Capabilities For Clinilabs 2Big data analysis identifies prognostic RNA markers in a common form of breast cancer 2Researchers track singing humpback whales on a Northwest Atlantic feeding ground 2
(Date:8/28/2014)... converters are important devices in spintronics, an electronic ... of electrons but also on their spin and ... of electric into magnetic signals and vice versa. ... from the Institute of Physics at Johannes Gutenberg ... UK, Prague, and Japan, has for the first ...
(Date:8/28/2014)... Aug. 28, 2014  Next month, executives from clinical trial ... industry events beginning with Patient-Centered Clinical Trials 2014 , ... Boston , September 4-5. Patient recruitment experts ... Aaron Fleishman will share insights on the benefits of ... of tactics – from media to mobile apps – can ...
(Date:8/28/2014)... 28, 2014  Armetheon, Inc. ( www.armetheon.com ), ... to late-stage cardiovascular drug candidates, today announced that ... round of financing. The Series A round was ... with participation from investors that included Atheneos Capital ... Larry Hsu , the founder of Impax ...
(Date:8/28/2014)... 28, 2014 A new market ... world is available from Strategic Consulting, Inc., the ... Industrial Microbiology Market Review, Fourth Edition: Global Review ... (IMMR—4) tracks and compares microbiology test volumes, market ... Europe and Asia, and forecasts future volumes and ...
Breaking Biology Technology:A new, tunable device for spintronics 2A new, tunable device for spintronics 3BBK Worldwide Leads Sessions at Key September Events 2Armetheon Completes $7.0 Million Series A Financing 2Armetheon Completes $7.0 Million Series A Financing 32 Billion Industrial Microbiology Tests Conducted for Product Quality and Safety Worldwide 22 Billion Industrial Microbiology Tests Conducted for Product Quality and Safety Worldwide 3
... and the University of California, Los Angeles (UCLA) have concluded ... chemistry for the rapid and robust labeling of proteins, peptides ... Emission Tomography (PET). "We are pleased ... cutting-edge work being developed by the Crump Institute," said Dr. ...
... Geim, a recipient of the 2010 Nobel Prize for graphene, ... electrons can magnetise graphene. The results, reported in ... the field of spintronics. Spintronics is a group of ... in addition to its fundamental electric charge that is exploited ...
... April 15, 2011 Carmell Therapeutics, a company that ... of injured tissues, has closed on a Series A ... facility and collect data for early clinical validation for ... was led by Harbor Light Capital Partners, a private ...
Cached Biology Technology:ImaginAb, Inc. Concludes Licensing Agreement With UCLA for Novel Radiochemistry Technology 2New spin on graphene 2Carmell Therapeutics Completes Series A Financing to Advance the Development of Novel Bioactive Plastics 2Carmell Therapeutics Completes Series A Financing to Advance the Development of Novel Bioactive Plastics 3
... is used to perform runs with ... the Experion automated electrophoresis system. The ... simulated gel views and summarizes size, ... Results table. This software is for ...
... Top cover cold rolled steel with stove ... surface polyethylene Front, ... 3 UV lamps Internal ... interlocked with fluorescent light Lighting ...
...
... this set of Antibody Microarray slides ... a total of over 2100 spots,including ... control. Antibodies belonging to many important ... cycle progression, signal transduction and gene ...
Biology Products: